The Invisible Disease: Depression

IntroductionDepression is a serious medical condition. Inoxidase inhibitors (MAOIs). Although both generations
contrast to the normal emotional experiences ofof medications are effective in relieving depression,
sadness, loss, or passing mood states, clinicalsome people will respond to one type of drug, but not
depression is persistent and can interfere significantlyanother. Other types of antidepressants are now in
with an individual's ability to function. There are threedevelopment.Certain types of psychotherapy,
main types of depressive disorders: major depressivespecifically cognitive-behavioral therapy (CBT) and
disorder, dysthymic disorder, and bipolar disorderinterpersonal therapy (IPT), have been found helpful for
(manic-depressive illness).Symptoms and Types ofdepression. Research indicates that mild to moderate
DepressionSymptoms of depression include sad mood,depression often can be treated successfully with
loss of interest or pleasure in activities that were onceeither therapy alone; however, severe depression
enjoyed, change in appetite or weight, difficulty sleepingappears more likely to respond to a combination of
or oversleeping, physical slowing or agitation, energypsychotherapy and medication. 7 More than 80
loss, feelings of worthlessness or inappropriate guilt,percent of people with depressive disorders improve
difficulty thinking or concentrating, and recurrentwhen they receive appropriate treatment.In situations
thoughts of death or suicide. A diagnosis of majorwhere medication, psychotherapy, and the combination
depressive disorder is made if a person has 5 or moreof these interventions prove ineffective, or work too
of these symptoms and impairment in usual functioningslowly to relieve severe symptoms such as psychosis
nearly every day during the same two-week period.(e.g., hallucinations, delusional thinking) or suicidality,
Major depression often begins between ages 15 to 30electroconvulsive therapy (ECT) may be considered.
but also can appear in children. 1 Episodes typicallyECT is a highly effective treatment for severe
recur.Some people have a chronic but less severedepressive episodes.The possibility of long-lasting
form of depression, called dysthymic disorder, which ismemory problems, although a concern in the past, has
diagnosed when depressed mood persists for at leastbeen significantly reduced with modern ECT
2 years (1 year in children) and is accompanied by attechniques. However, the potential benefits and risks of
least 2 other symptoms of depression. Many peopleECT, and of available alternative interventions, should
with dysthymia develop major depressivebe carefully reviewed and discussed with individuals
episodes.Episodes of depression also occur in peopleconsidering this treatment and, where appropriate, with
with bipolar disorder. In this disorder, depressionfamily or friends.One herbal supplement, hypericum or
alternates with mania, which is characterized bySt. John's wort, has been promoted as having
abnormally and persistently elevated mood or irritabilityantidepressant properties. Results from the first
and symptoms including overly-inflated self-esteem,large-scale, controlled study of St. John's wort for
decreased need for sleep, increased talkativeness,major depression, which was funded in part by NIMH,
racing thoughts, distractibility, physical agitation, andare expected in 2001. Note: There is evidence that St.
excessive risk taking. Because bipolar disorder requiresJohn's wort can reduce the effectiveness of certain
different treatment than major depressive disorder ormedications. Use of any herbal or natural supplements
dysthymia, obtaining an accurate diagnosis isshould always be discussed with your doctor before
extremely important.Facts About DepressionMajorthey are tried.Research FindingsBrain imaging research
depression is the leading cause of disability in the U.S.is revealing that in depression, neural circuits responsible
and worldwide. 2 Depressive disorders affect anfor moods, thinking, sleep, appetite, and behavior fail to
estimated 9.5 percent of adult Americans ages 18 andfunction properly, and that the regulation of critical
over in a given year, 3 or about 18.8 million people inneurotransmitters is impaired. Genetics research,
1998. Nearly twice as many women (12 percent) asincluding studies of twins, indicates that genes play a
men (7 percent) are affected by a depressiverole in depression. Vulnerability to depression appears
disorder each year.Depression can be devastating toto result from the influence of multiple genes acting
family relationships, friendships, and the ability to worktogether with environmental factors.Other research
or go to school. Many people still believe that thehas shown that stressful life events, particularly in the
emotional symptoms caused by depression are "notform of loss such as the death of a close family
real," and that a person should be able to shake offmember, may trigger major depression in susceptible
the symptoms. Because of these inaccurate beliefs,individuals. The hypothalamic-pituitary-adrenal (HPA)
people with depression either may not recognize thataxis, the hormonal system that regulates the body's
they have a treatable disorder or may be discouragedresponse to stress, is overactive in many people with
from seeking or staying on treatment due to feelingsdepression. Research findings suggest that persistent
of shame and stigma. Too often, untreated oroveractivation of this system may lay the groundwork
inadequately treated depression is associated withfor depression.Studies of brain chemistry, mechanisms
suicide.TreatmentsAntidepressant medications areof action of antidepressant medications, and the
widely used, effective treatments for depression.cognitive distortions and disturbed interpersonal
Existing antidepressants influence the functioning ofrelationships commonly associated with depression,
certain chemicals in the brain called neurotransmitters.continue to inform the development of new and better
The newer medications, such as the selectivetreatments.New Clinical TrialsNIMH is funding two new,
serotonin reuptake inhibitors (SSRIs), tend to havelarge-scale, multi-site clinical trials on treatments for
fewer side effects than the older drugs, which includemajor depression in adults and adolescents.
tricyclic antidepressants (TCAs) and monoamine